SCHEMBL6984463

SCHEMBL6984463

CC1Cc2cc(NS(=O)(=O)c3ccccc3)ccc2N(C(=O)CCc2ccc(C#N)cc2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
NR3C1 P04150 2/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
DRD3 P35462 1/20 0.41
HTR6 P50406 1/20 0.41
ADRB2 P07550 3/20 0.41
ADRB1 P08588 3/20 0.41
ADRB3 P13945 3/20 0.41
TRIM24 O15164 1/20 0.40
ATIC P31939 1/20 0.40
BRD4 O60885 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984210 0.86 KMT2A (0.55) KMT2AMEN1NR3C1DRD2HTR2A
SCHEMBL6984116 0.86 F2 (0.48) POLBKMT2AMEN1NR3C1KDM4E
Hydrochloric Acid SCHEMBL6983766 0.85 F2 (0.47) POLBKMT2AMEN1NR3C1KDM4E
SCHEMBL6977969 0.84 NR3C1 (0.56) KMT2AMEN1NR3C1DRD2HTR2A
SCHEMBL6985317 0.84 NR3C1 (0.58) KMT2AMEN1NR3C1LMNAADRB2
SCHEMBL6985046 0.83 KMT2A (0.43) POLBKMT2AMEN1NR3C1KDM4E
SCHEMBL6984466 0.83 TDP1 (0.38) POLBKMT2AHDAC4HDAC1HDAC8
SCHEMBL6981472 0.82 DRD2 (0.44) POLBKMT2AMEN1NR3C1KDM4E
SCHEMBL6986216 0.79 KMT2A (0.56) POLBKMT2AMEN1NR3C1LMNA
SCHEMBL6974883 0.79 TP53 (0.41) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed